VRTX - Company ID 0000875320
As of 2026-11-06, VERTEX PHARMACEUTICALS INC / MA (VRTX) has a market capitalization of $137.63 B, making it the #107 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $137.63 B |
| 2026-11-05 | $137.54 B |
| 2026-11-04 | $139.33 B |
| 2026-11-03 | $134.79 B |
| 2026-11-02 | $140.20 B |
| 2026-11-01 | $141.85 B |
| 2026-10-31 | $141.85 B |
| 2026-10-30 | $141.73 B |
| 2026-10-29 | $137.05 B |
| 2026-10-28 | $134.26 B |
| 2026-10-27 | $132.24 B |
| 2026-10-26 | $131.34 B |
As of 2026-11-06, VERTEX PHARMACEUTICALS INC / MA (VRTX) has a market capitalization of $137.63 B, making it the #107 most valuable US-listed company.
VERTEX PHARMACEUTICALS INC / MA is the #107 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $132.98 B |
| 2026-10-24 | $132.98 B |
| 2026-10-23 | $132.98 B |
| 2026-10-22 | $136.16 B |
| 2026-10-21 | $133.13 B |
| 2026-10-20 | $130.62 B |
| 2026-10-19 | $128.15 B |
| 2026-10-18 | $126.84 B |
| 2026-10-17 | $126.84 B |
| 2026-10-16 | $126.84 B |
| 2026-10-15 | $129.68 B |
| 2026-10-14 | $126.52 B |
| 2026-10-13 | $123.15 B |
| 2026-10-12 | $128.68 B |
| 2026-10-11 | $129.46 B |
| 2026-10-10 | $129.46 B |
| 2026-10-09 | $129.46 B |
| 2026-10-08 | $127.73 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.